MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. (Q53033550)

http://europepmc.org/abstract/MED/25040368

10 May 2018

title

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. (English)

1 reference

http://europepmc.org/abstract/MED/25040368

10 May 2018

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Massimo Roncalli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Alice Faversani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Lorenza Rimassa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Roberto Labianca

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Silvano Bosari

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Luca Di Tommaso

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Stefano Fagiuoli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Armando Santoro

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Carlo Carnaghi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Marco Maggioni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Claudia Augello

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Tiziana Pressiani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Gaia Spagnuolo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Elena Rota Caremoli

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Massimo Barberis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

21 July 2014

1 reference

http://europepmc.org/abstract/MED/25040368

10 May 2018

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Liver International

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1077-1086

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040368%20AND%20SRC:MED&resulttype=core&format=json

Sorafenib in advanced hepatocellular carcinoma

13 June 2020

cites work

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

21 January 2018

1 reference

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

21 January 2018

1 reference

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a

21 January 2018

1 reference

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

21 January 2018

1 reference

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

21 January 2018

1 reference

MicroRNAs in liver disease.

21 January 2018

1 reference

New strategies in hepatocellular carcinoma: genomic prognostic markers.

21 January 2018

1 reference

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

21 January 2018

1 reference

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma

21 January 2018

1 reference

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.

21 January 2018

1 reference

miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.

21 January 2018

1 reference

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

21 January 2018

1 reference

DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways

21 January 2018

1 reference

New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma

21 January 2018

1 reference

The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease

21 January 2018

1 reference

Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells

21 January 2018

1 reference

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

21 January 2018

1 reference

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer

21 January 2018

1 reference

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

21 January 2018

1 reference

Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status

21 January 2018

1 reference

Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer

21 January 2018

1 reference

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

21 January 2018

1 reference

A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

21 January 2018

1 reference

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

MicroRNA therapeutics in preclinical cancer models.

21 January 2018

1 reference

microRNAs in cancer management.

21 January 2018

1 reference

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.

21 January 2018

1 reference

MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma.

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference